Your browser doesn't support javascript.
loading
Dynamic analysis of circulating tumor DNA to predict the prognosis and monitor the treatment response of patients with metastatic triple-negative breast cancer: A prospective study.
Chi, Yajing; Su, Mu; Zhou, Dongdong; Zheng, Fangchao; Zhang, Baoxuan; Qiang, Ling; Ren, Guohua; Song, Lihua; Bu, Bing; Fang, Shu; Yu, Bo; Zhou, Jinxing; Yu, Jinming; Li, Huihui.
Affiliation
  • Chi Y; Department of Breast Medical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Su M; School of Medicine, Nankai University, Tianjin, China.
  • Zhou D; Department of Bioinformatics, Berry Oncology Corporation, Beijing, China.
  • Zheng F; Department of Breast Medical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Zhang B; Department of Breast Medical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Qiang L; Department of Breast Medical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Ren G; Department of Breast Medical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Song L; Department of Breast Medical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Bu B; Department of Breast Medical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Fang S; Department of Breast Medical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Yu B; Department of Breast Medical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Zhou J; Department of Bioinformatics, Berry Oncology Corporation, Beijing, China.
  • Yu J; Department of Bioinformatics, Berry Oncology Corporation, Beijing, China.
  • Li H; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Elife ; 122023 11 06.
Article in En | MEDLINE | ID: mdl-37929934
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triple Negative Breast Neoplasms / Circulating Tumor DNA Limits: Humans Language: En Journal: Elife Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triple Negative Breast Neoplasms / Circulating Tumor DNA Limits: Humans Language: En Journal: Elife Year: 2023 Document type: Article